IS5727A - Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva - Google Patents

Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Info

Publication number
IS5727A
IS5727A IS5727A IS5727A IS5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A
Authority
IS
Iceland
Prior art keywords
ghs
serm
selective
growth hormone
skeletal muscle
Prior art date
Application number
IS5727A
Other languages
English (en)
Icelandic (is)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5727A publication Critical patent/IS5727A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5727A 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva IS5727A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5727A true IS5727A (is) 2000-11-24

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5727A IS5727A (is) 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Country Status (29)

Country Link
EP (1) EP1085867A1 (no)
JP (1) JP2002518328A (no)
KR (1) KR20010052817A (no)
CN (1) CN1305378A (no)
AP (1) AP9901581A0 (no)
AR (1) AR018868A1 (no)
AU (1) AU3342099A (no)
BG (1) BG105128A (no)
BR (1) BR9911357A (no)
CA (1) CA2335112A1 (no)
CO (1) CO5070586A1 (no)
EA (1) EA200001189A1 (no)
GT (1) GT199900083A (no)
HR (1) HRP20000857A2 (no)
HU (1) HUP0102395A2 (no)
ID (1) ID26726A (no)
IL (1) IL139587A0 (no)
IS (1) IS5727A (no)
MA (1) MA26648A1 (no)
NO (1) NO20006381L (no)
OA (1) OA11569A (no)
PA (1) PA8472101A1 (no)
PE (1) PE20000633A1 (no)
PL (1) PL345064A1 (no)
SK (1) SK18902000A3 (no)
TN (1) TNSN99118A1 (no)
UY (1) UY25557A1 (no)
WO (1) WO1999065488A1 (no)
ZA (1) ZA993973B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
MXPA04005112A (es) * 2001-11-29 2005-04-29 Gtx Inc Prevencion y tratamiento de osteoporosis inducida por privacion de androgeno.
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
SK18902000A3 (sk) 2001-12-03
JP2002518328A (ja) 2002-06-25
BG105128A (en) 2001-11-30
PL345064A1 (en) 2001-11-19
AU3342099A (en) 2000-01-05
BR9911357A (pt) 2001-03-13
HRP20000857A2 (en) 2001-10-31
ZA993973B (en) 2000-12-15
WO1999065488A1 (en) 1999-12-23
CO5070586A1 (es) 2001-08-28
OA11569A (en) 2004-07-01
CA2335112A1 (en) 1999-12-23
NO20006381D0 (no) 2000-12-14
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
HUP0102395A2 (hu) 2001-11-28
KR20010052817A (ko) 2001-06-25
AR018868A1 (es) 2001-12-12
CN1305378A (zh) 2001-07-25
PE20000633A1 (es) 2000-07-26
ID26726A (id) 2001-02-01
GT199900083A (es) 2000-12-05
AP9901581A0 (en) 1999-06-30
TNSN99118A1 (fr) 2005-11-10
EP1085867A1 (en) 2001-03-28
NO20006381L (no) 2000-12-14
EA200001189A1 (ru) 2001-06-25
IL139587A0 (en) 2002-02-10
MA26648A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
IS2390B (is) Aðferð við að fjarlægja vöðvakjöt af fiski og tæki til að framkvæma þá aðferð
EP1143987A4 (en) NATURAL COMPOSITION AND METHOD FOR TREATING SEXUAL DYSFUNCTIONS
ID23496A (id) Ekstrak tanaman untuk mengobati peningkatan resorpsi tulang
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
EP1071841A4 (en) METHOD AND DEVICE FOR COUNTERFLOW TREATMENT OF SLUDGE
DK0861588T3 (da) Fremgangsmåde til sterilisering af jord og tilhørende udstyr
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
ZA984172B (en) Method of water treatment using zeolite crystalloid coagulants
DK0682973T3 (da) Fremgangsmåde til katalytisk desodorisation og nedsættelse af nitrogenindholdet i udløb fra gødningsbassin
EP1265583A4 (en) METHOD FOR THE TREATMENT OF SKIN DISEASES
IS5691A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva
GB2333290B (en) Method of water treatment using zeolite crystalloid coagulants
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
EP1296889A4 (en) PLASTICIZED MIXTURE AND METHOD OF USING THE MIXTURE
IL139587A0 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
BR9508718A (pt) Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos
NO20021947D0 (no) Bio-b¶rende matrikser, fremgangsmåte for fremstilling og anvendelse derav
DK0931454T3 (da) Apparat til findeling og blanding af foderkomponenter til dyrefoder
NO20032969L (no) Fremgangsmåte for screening med hensyn på progesteronreseptorisoform-spesifikke ligander og med hensyn på vevs-selektiveprogesteronreseptorligander
EP1150669A4 (en) FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
DK1244662T3 (da) Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter
GB0010430D0 (en) Method and apparatus for non-manual installation of software,such as NT services